Moreover, when treating COVID‐19 patients with dexamethasone, there is a significant reduction in the inflammatory cytokine storm, which is generated by a range of immune cells, including macrophages, and includes inflammatory factors such as IL‐1β and TNF‐α [31]. The gene discussed is IL1B; the disease is COVID-19.